Download
1 / 4
0 likes | 4 Views
Digital pathology enables pathologists to collaborate and work remotely on cases by improving the accuracy of diagnostic techniques and allowing the sharing of digital images beyond geographical limitations. Before the outbreak of COVID-19, the adoption of digital pathology was extremely low due to stringent federal regulations of the U.S. FDA. The adoption increased due to the relaxation of FDA requirements for validating and approving digital pathology-related technology to meet the increased demand during the pandemic.
E N D
Transforming Healthcare with Digital Pathology: Trends and Opportunities
Global Digital Pathology Market – 2024-2030 According to a recent publication by Meticulous Research®, the global digital pathology market is forecasted to reach $1.86 billion by 2030, growing at a robust CAGR of 8.7% during the forecast period. This growth is underpinned by factors such as the rising prevalence of cancer, increasing research on biomarkers, the growing number of clinical trials for oncology drugs, and the rising demand for accurate detection of genetic and rare diseases. The rapid adoption of teleconsulting, coupled with advancements in precision medicine, further bolsters the market’s expansion. Market Segmentation The digital pathology market is categorized into the following segments: 1.Offering: Hardware, Software, Services 2.Application: Disease Diagnosis, Drug Discovery & Development, Education and Training, Teleconsultation 3.End User: Hospitals & Clinics, Diagnostic Laboratories, Research Institutes & Academics, Pharmaceutical & Biotechnology Companies 4.Geography: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa Key Market Insights 1. Offering Segment The hardware segment is anticipated to dominate the market in 2024, driven by: oThe global burden of chronic diseases requiring precise diagnostic tools. oAn increasing shift toward digital solutions in pathology. oThe rising demand for tissue microarrays, scanners, and other critical hardware components. • 2. Application Segment Disease diagnosis holds the largest market share, supported by: oThe aging global population prone to chronic diseases. oIncreased adoption of teleconsulting, particularly post-COVID-19 pandemic. oInnovations in pathology facilitating quicker and more accurate disease detection. • 3. End User Segment The hospitals & clinics segment is expected to lead, attributed to: oA growing number of healthcare facilities worldwide. oIncreasing demand for digital pathology tools amid a declining number of pathologists. oOngoing research in precision medicine, driving adoption in clinical settings. • 4. Geographic Trends Page 1 of 3 © Meticulous Research| sales@meticulousresearch.com
Global Digital Pathology Market – 2024-2030 North America is set to maintain its leadership in the global market, driven by: oHigh investment in R&D and digital infrastructure. oWidespread adoption of advanced diagnostic technologies. oAn established healthcare system with a strong focus on early disease detection. oThe U.S. is projected to dominate the region’s share. Europe and Asia-Pacific follow closely, with Asia-Pacific registering rapid growth owing to increasing healthcare investments in countries like China and India. • • Competitive Landscape Prominent players in the digital pathology market include: 3DHISTECH Ltd. (Hungary), Leica Microsystems (a subsidiary of Danaher Corporation) (Germany), Hamamatsu Photonics K.K. (Japan), Nikon Corporation (Japan), Visiopharm A/S (Denmark), Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Glencoe Software, Inc. (U.S.), XIFIN, Inc. (U.S.), and PerkinElmer Inc. (U.S.). These companies are leveraging technological advancements to innovate and expand their product portfolios, catering to the growing demand for digital pathology solutions. Growth Drivers 1.High Prevalence of Cancer: The increasing global cancer burden has amplified the demand for efficient diagnostic tools. 2.Advancements in Biomarkers: The growing availability of biomarkers is enhancing diagnostic accuracy and therapeutic applications. 3.Demand for Teleconsulting: The post-pandemic era has seen a significant rise in telepathology for faster and remote consultations. 4.Precision Medicine: The emphasis on personalized treatment strategies continues to drive market growth. Opportunities The digital pathology market is poised to benefit from: The increasing focus on precision medicine in emerging economies. Continuous advancements in AI-driven diagnostic tools. Expanding telehealth infrastructure worldwide. • • • Conclusion The digital pathology market is at the cusp of transformation, fueled by technological advancements and evolving healthcare demands. With strong growth prospects across key regions and increasing adoption in clinical and research settings, the market presents abundant opportunities for stakeholders. As precision medicine and teleconsulting gain momentum, digital pathology is set to play a pivotal role in revolutionizing global healthcare systems. Page 2 of 3 © Meticulous Research| sales@meticulousresearch.com
Global Digital Pathology Market – 2024-2030 Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 © Meticulous Research| sales@meticulousresearch.com
